Ricky D Shafer
Examiner (ID: 1251)
Most Active Art Unit | 2872 |
Art Unit(s) | 2507, 2872 |
Total Applications | 2439 |
Issued Applications | 1744 |
Pending Applications | 164 |
Abandoned Applications | 501 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 1022036
[patent_doc_number] => 06887977
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-03
[patent_title] => 'Methods and materials relating to CD8-tropic HIV-1'
[patent_app_type] => utility
[patent_app_number] => 10/040802
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9151
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887977.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040802
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040802 | Methods and materials relating to CD8-tropic HIV-1 | Dec 27, 2001 | Issued |
Array
(
[id] => 6869831
[patent_doc_number] => 20030082520
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Procedure for quantitative determination of viral particles having a cholesterol-containing envelope'
[patent_app_type] => new
[patent_app_number] => 10/033041
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2750
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0082/20030082520.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033041 | Procedure for quantitative determination of viral particles having a cholesterol-containing envelope | Dec 26, 2001 | Abandoned |
Array
(
[id] => 1253824
[patent_doc_number] => 06670466
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-30
[patent_title] => 'Human endogenous retrovirus in breast cancer'
[patent_app_type] => B1
[patent_app_number] => 10/018865
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 5
[patent_no_of_words] => 14369
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/670/06670466.pdf
[firstpage_image] =>[orig_patent_app_number] => 10018865
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/018865 | Human endogenous retrovirus in breast cancer | Dec 18, 2001 | Issued |
Array
(
[id] => 6534536
[patent_doc_number] => 20020137025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Method and system for anonymously testing for a human malady'
[patent_app_type] => new
[patent_app_number] => 10/015133
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8444
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 215
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20020137025.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015133
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015133 | Method and system for anonymously testing for a human malady | Dec 10, 2001 | Abandoned |
Array
(
[id] => 1285445
[patent_doc_number] => 06635246
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Inactivated influenza virus vaccine for nasal or oral application'
[patent_app_type] => B1
[patent_app_number] => 09/913400
[patent_app_country] => US
[patent_app_date] => 2001-12-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3789
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635246.pdf
[firstpage_image] =>[orig_patent_app_number] => 09913400
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/913400 | Inactivated influenza virus vaccine for nasal or oral application | Dec 4, 2001 | Issued |
10/012212 | Ligands to enhance specific cellular uptake of biomolecules | Nov 29, 2001 | Abandoned |
Array
(
[id] => 1261059
[patent_doc_number] => 06664042
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-12-16
[patent_title] => 'Determining viral load in double negative T cells'
[patent_app_type] => B1
[patent_app_number] => 09/890010
[patent_app_country] => US
[patent_app_date] => 2001-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 28
[patent_no_of_words] => 13021
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/664/06664042.pdf
[firstpage_image] =>[orig_patent_app_number] => 09890010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/890010 | Determining viral load in double negative T cells | Nov 22, 2001 | Issued |
Array
(
[id] => 6778192
[patent_doc_number] => 20030049273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin'
[patent_app_type] => new
[patent_app_number] => 10/050875
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 24104
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20030049273.pdf
[firstpage_image] =>[orig_patent_app_number] => 10050875
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/050875 | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin | Nov 19, 2001 | Issued |
Array
(
[id] => 6377144
[patent_doc_number] => 20020119444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance'
[patent_app_type] => new
[patent_app_number] => 09/988010
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7982
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119444.pdf
[firstpage_image] =>[orig_patent_app_number] => 09988010
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/988010 | Rapid single-cycle assay for human immunodeficiency virus type 1 drug resistance | Nov 15, 2001 | Issued |
Array
(
[id] => 6429106
[patent_doc_number] => 20020127207
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-12
[patent_title] => 'Compositions and methods for reducing the amount of salmonella in livestock'
[patent_app_type] => new
[patent_app_number] => 09/986419
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5446
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0127/20020127207.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986419
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986419 | Compositions and methods for reducing the amount of salmonella in livestock | Nov 7, 2001 | Issued |
Array
(
[id] => 1342679
[patent_doc_number] => 06582697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-24
[patent_title] => 'Enhancement of the cellular immune response'
[patent_app_type] => B2
[patent_app_number] => 09/986049
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3311
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/582/06582697.pdf
[firstpage_image] =>[orig_patent_app_number] => 09986049
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/986049 | Enhancement of the cellular immune response | Nov 6, 2001 | Issued |
Array
(
[id] => 6744975
[patent_doc_number] => 20030022158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus'
[patent_app_type] => new
[patent_app_number] => 09/992896
[patent_app_country] => US
[patent_app_date] => 2001-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10762
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022158.pdf
[firstpage_image] =>[orig_patent_app_number] => 09992896
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/992896 | Peptides from the TT virus sequence and monospecific antibodies binding to the TT virus | Nov 4, 2001 | Abandoned |
Array
(
[id] => 5873794
[patent_doc_number] => 20020048748
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Methods of therapy for HIV infection'
[patent_app_type] => new
[patent_app_number] => 09/974470
[patent_app_country] => US
[patent_app_date] => 2001-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10220
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20020048748.pdf
[firstpage_image] =>[orig_patent_app_number] => 09974470
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/974470 | Methods of therapy for HIV infection | Oct 8, 2001 | Issued |
Array
(
[id] => 793043
[patent_doc_number] => 06982088
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-03
[patent_title] => 'Vaccine composition and stabilization method using high molecular weight PVP'
[patent_app_type] => utility
[patent_app_number] => 10/381948
[patent_app_country] => US
[patent_app_date] => 2001-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2487
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/982/06982088.pdf
[firstpage_image] =>[orig_patent_app_number] => 10381948
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/381948 | Vaccine composition and stabilization method using high molecular weight PVP | Oct 7, 2001 | Issued |
Array
(
[id] => 5814233
[patent_doc_number] => 20020039570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-04
[patent_title] => 'Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases'
[patent_app_type] => new
[patent_app_number] => 09/969866
[patent_app_country] => US
[patent_app_date] => 2001-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4694
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20020039570.pdf
[firstpage_image] =>[orig_patent_app_number] => 09969866
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/969866 | Orally-administrable therapeutic and/or prophylactic agent for HTLV-1-related diseases | Oct 3, 2001 | Abandoned |
Array
(
[id] => 6817698
[patent_doc_number] => 20030068656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-10
[patent_title] => 'Test strip for detecting gastric problems based on the presence of urease'
[patent_app_type] => new
[patent_app_number] => 09/970415
[patent_app_country] => US
[patent_app_date] => 2001-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4185
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20030068656.pdf
[firstpage_image] =>[orig_patent_app_number] => 09970415
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/970415 | Test strip for detecting gastric problems based on the presence of urease | Oct 1, 2001 | Issued |
Array
(
[id] => 6327025
[patent_doc_number] => 20020197734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-26
[patent_title] => 'Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients'
[patent_app_type] => new
[patent_app_number] => 09/963064
[patent_app_country] => US
[patent_app_date] => 2001-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13674
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20020197734.pdf
[firstpage_image] =>[orig_patent_app_number] => 09963064
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/963064 | Analysis of HIV-1 coreceptor use in the clinical care of HIV-1-infected patients | Sep 24, 2001 | Issued |
Array
(
[id] => 6017617
[patent_doc_number] => 20020103344
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Glycoprotein mutants of retrovirus envelopes and their biological applications'
[patent_app_type] => new
[patent_app_number] => 09/960653
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7299
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0103/20020103344.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960653
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960653 | Glycoprotein mutants of retrovirus envelopes and their biological applications | Sep 23, 2001 | Abandoned |
Array
(
[id] => 6624893
[patent_doc_number] => 20020086283
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Immunogen'
[patent_app_type] => new
[patent_app_number] => 09/960717
[patent_app_country] => US
[patent_app_date] => 2001-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 9375
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086283.pdf
[firstpage_image] =>[orig_patent_app_number] => 09960717
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/960717 | Immunogen comprising an HIV envelope protein, a ligand and H2 peptide | Sep 23, 2001 | Issued |
09/913525 | VACCINE COMPOSITIONS AGAINST INFECTIOUS PATHOLOGIES FOR MAMMALS | Sep 11, 2001 | Abandoned |